Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Molecular Cancer Therapeutics|April 18, 2009
DNA fingerprinting of the NCI-60 cell line panelPhilip L Lorenzi, William C Reinhold, Sudhir Varma, et al.
Plos One|September 9, 2017
Effect of pre-analytic variables on the reproducibility of qPCR relative telomere length measurementCasey L Dagnall, Belynda Hicks, Kedest Teshome, et al.
Neuro-Oncology|June 20, 2008
Genetic variation in insulin-like growth factors and brain tumor riskStefan Lönn, Nathaniel Rothman, William R Shapiro, et al.
Cancer Causes & Control : CCC|January 18, 2006
Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland)Farin Kamangar, Christian C Abnet, Amy A Hutchinson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 9, 2007
Whole-genome amplification of oral rinse self-collected DNA in a population-based case-control study of breast cancerXueying Liang, Amy Trentham-Dietz, Linda Titus-Ernstoff, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 16, 2012
Common obesity-related genetic variants and papillary thyroid cancer riskCari M Kitahara, Gila Neta, Ruth M Pfeiffer, et al.
Molecular Cancer Therapeutics|October 15, 2008
Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell linesPhilip L Lorenzi, Jenny Llamas, Michele Gunsior, et al.
Carcinogenesis|June 7, 2011
Common genetic variants related to genomic integrity and risk of papillary thyroid cancerGila Neta, Alina V Brenner, Erich M Sturgis, et al.
Thyroid : Official Journal of the American Thyroid Association|January 10, 2012
Common genetic variants in sex hormone pathway genes and papillary thyroid cancer riskSara J Schonfeld, Gila Neta, Erich M Sturgis, et al.
Pageof 2